$CV News

CapsoVision Inc (NASDAQ:CV) Q1 2026 Miss Sends Stock Down 8% in After-Hours Trading

CapsoVision Q1 Earnings Call Highlights

CapsoVision Reports First Quarter 2026 Financial Results

CapsoVision, Inc. (CV) Q1 2026 Earnings Call Transcript

Transcript: CapsoVision Q1 2026 Earnings Conference Call

CapsoVision Q1 EPS $(0.15) Misses $(0.13) Estimate, Sales $2.792M Miss $3.188M Estimate

CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026

CapsoVision Files Prospectus Related To Resale Of 2,867,089 Common Shares By Selling Stockholders

Benchmark Maintains Speculative Buy on CapsoVision, Lowers Price Target to $10

CapsoVision Q4 Earnings Call Highlights

CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results

CapsoVision, Inc. (CV) Q4 2025 Earnings Call Transcript

CapsoVision Q4 EPS $0.02 Beats $(0.14) Estimate, Sales $3.918M Miss $4.151M Estimate.

CapsoVision Conference: CEO Maps AI-Driven Capsule Endoscopy Roadmap for Colon and Pancreas Screening

CapsoVision shares are trading higher after the company announced the closing of a $14 million private placement in public equity financing.

CapsoVision shares are trading higher after the company announced the closing of a $14 million private placement in public equity financing.

CapsoVision Announces $14 Million Private Placement Financing

CapsoVision Closes $14M Private Placement In Public Equity Financing

CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026

CapsoVision to Participate in the 38th Annual ROTH Conference